Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Nonfunctional Neuroendocrine Neoplasms (REMAIN Trial)

NCT07842172 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07842172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07842172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Nonfunctional Neuroendocrine Neoplasms (REMAIN Trial)
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2034
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteropancreatic neuroendocrine neoplasm, neuroendocrine neoplasm